Injectafer 750 MG/15 ML vial 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,980
Award facts
- Contract value 100% obligated
- $52,980.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,980.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials, with an ultimate completion date of February 2, 2026. This non-set-aside contract was competitively awarded on January 30, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains on a competitive basis. This particular order for Injectafer, an iron replacement therapy used in treating iron deficiency anemia, supports the Defense Health Agency and other military medical treatment facilities that depend on DLA's pharmaceutical supply chain to maintain operational readiness and troop healthcare standards.
Quick answers
Who was awarded contract SPE2DR26FN1L5?
SPE2DR26FN1L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FN1L5 worth?
The government has obligated $52,980 on SPE2DR26FN1L5.
Is contract SPE2DR26FN1L5 an order under another contract?
Yes. SPE2DR26FN1L5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1L5 competed?
The extent of competition for SPE2DR26FN1L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award